Skip to main content
BYAH
NASDAQ Industrial Applications And Services

Park Ha Biological Reports $918K Net Loss, Cash Plummets to $628K; Massive Dilution Authorized

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
9
Price
$0.39
Mkt Cap
$2.48M
52W Low
$0.365
52W High
$45
52W Position info
6.8% above low
Off High info
99% below high
Rel. Volume
Market data snapshot near publication time

BYAH is trading near its 52-week low of $0.365 (6.8% above the low).

Summary

Park Ha Biological Technology reported a $918K net loss for the six months ended April 30, 2026, with cash collapsing to $628K. The company has authorized a massive increase in shares to 300 billion and completed a $1.74M offering at $1.50 per share — a stark contrast to the current $0.39 stock price.


Key Events · Earnings and Guidance · BYAH

  • Net Loss of $918K on $1.26M Revenue

    The company reported a net loss of $918,282 for the six months ended April 30, 2026, a 95% improvement from the prior-year period's $19.84M loss, which was driven by a one-time $19.95M share-based compensation charge. Revenue was essentially flat at $1.26M.

  • Cash Collapses to $628K

    Cash and cash equivalents fell from $3.79M to $628K in six months. Operating activities used $114K, while investing activities consumed $5.35M, primarily for short-term investments. The company raised $2.24M from share issuances to partially offset the burn.

  • Franchisee Loan Losses Surge

    The allowance for expected credit losses on loans to franchisees increased to $534,173 from $232,876, reflecting a sharp rise in past-due loans. This signals significant distress in the franchise network, which is the company's primary revenue driver.

  • Massive Dilution Authorized

    Subsequent to the period end, shareholders approved an increase in authorized shares to 300 billion, up from 3 billion. The board also received authority to effect reverse stock splits of up to 5,000-for-1, giving it broad power to manage the share price and issue vast amounts of new equity.


Analysis · BYAH · Industrial Applications And Services

Park Ha Biological Technology's interim results reveal a company burning cash at an alarming rate while simultaneously laying the groundwork for extreme dilution. The net loss of $918,282 is a 95% improvement from the prior year, but only because the prior period included a one-time $19.95M share-based compensation charge — the underlying business generated just $1.26M in revenue with a $963K operating loss. Cash has collapsed from $3.79M to $628K in six months, driven by $5.35M in investing outflows (mostly short-term investments) and an operating cash burn of $114K. The company raised $2.24M from share issuances during the period, and subsequent events show it raised another $1.74M in a registered direct offering at $1.50 per share — a price that is nearly 4x the current $0.39 stock price, suggesting the offering was priced before the stock's collapse. Most critically, shareholders have approved an increase in authorized shares to 300 billion, giving the board a blank check for massive future dilution. The allowance for credit losses on franchisee loans surged to $534K, signaling deep distress in the franchise network. This filing paints a picture of a micro-cap company in survival mode, burning cash, diluting shareholders, and preparing for even more dilution — all while the stock trades near its lows.

At the time of this filing, BYAH was trading at $0.39 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $0.37 to $45.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BYAH - Latest Insights

BYAH
Jul 13, 2026, 7:47 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.5234
Real-time Price: $0.3897 info
Change: -$0.1337 (-26%) info
Market Cap: $2.48M info
BYAH
Jul 06, 2026, 2:25 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.760
Real-time Price: $0.3897 info
Change: -$0.3703 (-49%) info
Market Cap: $2.48M info
BYAH
Jul 06, 2026, 11:42 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.8014
Real-time Price: $0.3897 info
Change: -$0.4117 (-51%) info
Market Cap: $2.48M info
BYAH
Jul 01, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.05
Real-time Price: $0.3897 info
Change: -$0.6603 (-63%) info
Market Cap: $2.48M info
BYAH
Jul 01, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.9999
Real-time Price: $0.3897 info
Change: -$0.6102 (-61%) info
Market Cap: $2.48M info